|
1
|
Abu-Amero KK, Helwa I, Al-Muammar A,
Strickland S, Hauser MA, Allingham RR and Liu Y: Screening of the
seed region of MIR184 in keratoconus patients from Saudi Arabia.
Biomed Res Int. 2015:6045082015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cristobal I, Madoz-Gurpide J,
Martin-Aparicio E, Carames C, Aguilera O, Rojo F and
Garcia-Foncillas J: Comment on ‘TAp63 suppress metastasis via
miR-133b in colon cancer cells’. Br J Cancer. 111:23692014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kubisch J, Türei D, Földvári-Nagy L, Dunai
ZA, Zsákai L, Varga M, Vellai T, Csermely P and Korcsmáros T:
Complex regulation of autophagy in cancer - integrated approaches
to discover the networks that hold a double-edged sword. Semin
Cancer Biol. 23:252–261. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shih IM and Kurman RJ: p63 expression is
useful in the distinction of epithelioid trophoblastic and
placental site trophoblastic tumors by profiling trophoblastic
subpopulations. Am J Surg Pathol. 28:1177–1183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bassampour SA, Abdi R, Bahador R, Shakeri
M, Torkaman A, Yahaghi E and Taheriazam A: Downregulation of
miR-133b/miR-503 acts as efficient prognostic and diagnostic
factors in patients with osteosarcoma and these predictor
biomarkers are correlated with overall survival. Tumour Biol. Aug
16–2015.(Epub ahead of print). PubMed/NCBI
|
|
6
|
Guzel E, Karatas OF, Semercioz A, Ekici S,
Aykan S, Yentur S, Creighton CJ, Ittmann M and Ozen M:
Identification of microRNAs differentially expressed in prostatic
secretions of patients with prostate cancer. Int J Cancer.
136:875–879. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Duan FT, Qian F, Fang K, Lin KY, Wang WT
and Chen YQ: miR-133b, a muscle-specific microRNA, is a novel
prognostic marker that participates in the progression of human
colorectal cancer via regulation of CXCR4 expression. Mol Cancer.
12:1642013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao Y, Huang J, Zhang L, Qu Y, Li J, Yu
B, Yan M, Yu Y, Liu B and Zhu Z: MiR-133b is frequently decreased
in gastric cancer and its overexpression reduces the metastatic
potential of gastric cancer cells. BMC Cancer. 14:342014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li X, Wan X, Chen H, Yang S, Liu Y, Mo W,
Meng D, Du W, Huang Y, Wu H, et al: Identification of miR-133b and
RB1CC1 as independent predictors for biochemical recurrence and
potential therapeutic targets for prostate cancer. Clin Cancer Res.
20:2312–2325. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ellermeier C, Vang S, Cleveland K, Durand
W, Resnick MB and Brodsky AS: Prognostic microRNA expression
signature from examination of colorectal primary and metastatic
tumors. Anticancer Res. 34:3957–3967. 2014.PubMed/NCBI
|
|
11
|
Akçakaya P, Ekelund S, Kolosenko I,
Caramuta S, Ozata DM, Xie H, Lindforss U, Olivecrona H and Lui WO:
miR-185 and miR-133b deregulation is associated with overall
survival and metastasis in colorectal cancer. Int J Oncol.
39:311–318. 2011.PubMed/NCBI
|
|
12
|
Das RK, Anura A, Pal M, Bag S, Majumdar S,
Barui A, Chakraborty C, Ray AK, Sengupta S, Paul RR, et al:
Epithelio-mesenchymal transitional attributes in oral sub-mucous
fibrosis. Exp Mol Pathol. 95:259–269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Yan W and Chen X: P63 regulates
tubular formation via epithelial-to-mesenchymal transition.
Oncogene. 33:1548–1557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Celardo I, Grespi F, Antonov A, Bernassola
F, Garabadgiu AV, Melino G and Amelio I: Caspase-1 is a novel
target of p63 in tumor suppression. Cell Death Dis. 4:e6452013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tucci P, Agostini M, Grespi F, Markert EK,
Terrinoni A, Vousden KH, Muller PA, Dötsch V, Kehrloesser S, Sayan
BS, et al: Loss of p63 and its microRNA-205 target results in
enhanced cell migration and metastasis in prostate cancer. Proc
Natl Acad Sci USA. 109:15312–15317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CW, Li XR, Zhang Y, Hu G, Guo YH, Zhou
JY, Du J, Lv L, Gao K, Zhang Y, et al: TAp63 suppress metastasis
via miR-133b in colon cancer cells. Br J Cancer. 110:2310–2320.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao QW, Hua LD, Wang J, Fan CX, Deng WY,
Li B, Bian WJ, Shao CX, He N, Zhou P, et al: A point mutation in
SCN1A 5 genomic region decreases the promoter activity and is
associated with mild epilepsy and seizure aggravation induced by
antiepileptic drug. Mol Neurobiol. Mar 11–2016.(Epub ahead of
print). View Article : Google Scholar
|
|
18
|
Brooks MB, Catalfamo JL, MacNguyen R, Tim
D, Fancher S and McCardle JAA: A TMEM16F point mutation causes an
absence of canine platelet TMEM16F and ineffective activation and
death-induced phospholipid scrambling. J Thromb Haemost.
13:2240–2252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tan X, Wang H, Luo G, Ren S, Li W, Cui J,
Gill HS, Fu SW and Lu Y: Clinical significance of a point mutation
in DNA polymerase beta (POLB) gene in gastric cancer. Int J Biol
Sci. 11:144–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HC, Yang CW, Chen CY and Au LC: Single
point mutation of microRNA may cause butterfly effect on alteration
of global gene expression. Biochem Biophys Res Commun.
404:1065–1069. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Palatnik JF, Wollmann H, Schommer C,
Schwab R, Boisbouvier J, Rodriguez R, Warthmann N, Allen E,
Dezulian T, Huson D, et al: Sequence and expression differences
underlie functional specialization of Arabidopsis microRNAs miR159
and miR319. Dev Cell. 13:115–125. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yamaki T, Suenaga Y, Iuchi T, Alagu J,
Takatori A, Itami M, Araki A, Ohira M, Inoue M, Kageyama H, et al:
Temozolomide suppresses MYC via activation of TAp63 to inhibit
progression of human glioblastoma. Sci Rep. 3:11602013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loljung L, Coates PJ, Nekulova M, Laurell
G, Wahlgren M, Wilms T, Widlöf M, Hansel A and Nylander K: High
expression of p63 is correlated to poor prognosis in squamous cell
carcinoma of the tongue. J Oral Pathol Med. 43:14–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bahnassy AA, Zekri AR, Salem SE, Abou-Bakr
AA, Sakr MA, Abdel-Samiaa AG and Al-Bradei M: Differential
expression of p53 family proteins in colorectal adenomas and
carcinomas: Prognostic and predictive values. Histol Histopathol.
29:207–216. 2014.PubMed/NCBI
|
|
25
|
Spiesbach K, Tannapfel A, Mössner J and
Engeland K: TAp63gamma can substitute for p53 in inducing
expression of the maspin tumor suppressor. Int J Cancer.
114:555–562. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv LV, Zhou J, Lin C, Hu G, Yi LU, Du J,
Gao K and Li X: DNA methylation is involved in the aberrant
expression of miR-133b in colorectal cancer cells. Oncol Lett.
10:907–912. 2015.PubMed/NCBI
|
|
27
|
Tahiri A, Leivonen SK, Lüders T, Steinfeld
I, Aure M Ragle, Geisler J, Mäkelä R, Nord S, Riis ML, Yakhini Z,
et al: Deregulation of cancer-related miRNAs is a common event in
both benign and malignant human breast tumors. Carcinogenesis.
35:76–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ren J, Huang HJ, Gong Y, Yue S, Tang LM
and Cheng SY: MicroRNA-206 suppresses gastric cancer cell growth
and metastasis. Cell Biosci. 4:262014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Z, Kim K, Li X, Moreno M, Sharp T,
Goodheart MJ, Safe S, Dupuy AJ and Amendt BA: MicroRNA-26b
represses colon cancer cell proliferation by inhibiting lymphoid
enhancer factor 1 expression. Mol Cancer Ther. 13:1942–1951. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen AX, Yu KD, Fan L, Li JY, Yang C,
Huang AJ and Shao ZM: Germline genetic variants disturbing the
Let-7/LIN28 double-negative feedback loop alter breast cancer
susceptibility. PLoS Genet. 7:e10022592011. View Article : Google Scholar : PubMed/NCBI
|
